Actively Recruiting
ExoLuminate Study for Early Detection of Pancreatic Cancer
Led by Biological Dynamics · Updated on 2025-07-28
1000
Participants Needed
1
Research Sites
262 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
ExoLuminate is a nationally-enrolling registry study designed for earlier detection of cancer in patients at elevated risk or clinically-suspicious for pancreatic ductal adenocarcinoma (PDAC). Those with elevated risk for PDAC can include individuals with intraductal papillary mucinous neoplasms, family history of pancreatic cancer, germline mutations in genes known to be associated with cancer, and a personal or family history of pancreatitis. The goal of the study is to compare the performance of ExoVerita™ assay in early detection of PDAC to current standard-of-care methods of surveillance.
CONDITIONS
Official Title
ExoLuminate Study for Early Detection of Pancreatic Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years old or older
- Meet criteria for one of the study cohorts
- Able to give informed consent
- Able to provide a blood sample
You will not qualify if you...
- Under 18 years old
- Pregnant
- Active cancer other than pancreatic cancer or undergoing treatment for active cancer (except skin malignancies)
- Prior organ transplant or bone marrow transplant
- History of fainting or adverse effects when blood is drawn
- Any condition that investigator believes should prevent enrollment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Biological Dynamics
San Diego, California, United States, 92121
Actively Recruiting
Research Team
H
Harmeet Dhani, MD, M.Sc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
8
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here